Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.
about
Sesquiterpene lactones downregulate G2/M cell cycle regulator proteins and affect the invasive potential of human soft tissue sarcoma cellsNovel therapeutic targets for pancreatic cancerA novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase muMangiferin and Cancer: Mechanisms of Action.Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysisBiomarkers of pediatric brain tumorsTargeting bone physiology for the treatment of metastatic prostate cancerMolecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironmentPotential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactoneThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerToxin-based therapeutic approachesSelective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal CancerSynthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesAssociation of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.Vascular proteomics in metabolic and cardiovascular diseasesMultidimensional Roles of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in Malignant CancersRole of RUNX2 in Breast CarcinogenesisMatrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionIrradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivoATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarizationSmart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriersA disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implicationsUltrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.Non-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography.MMP-14 is necessary but not sufficient for invasion of three-dimensional collagen by human muscle satellite cells.Hypoxia, inflammation, and the tumor microenvironment in metastatic diseaseEffects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivo37-kDa laminin receptor precursor mediates GnRH-II-induced MMP-2 expression and invasiveness in ovarian cancer cells.Antiangiogenetic effects of 4 varieties of grapes in vitro.Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.Matrix metalloproteinase 1 and circulating tumor cells in early breast cancerMT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer.Emerging roles of PDGF-D signaling pathway in tumor development and progression.What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013.Angiogenesis and progression in human melanoma.What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?MMP-1 expression has an independent prognostic value in breast cancer.Validation of a blood protein signature for non-small cell lung cancerMatrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma
P2860
Q21133015-366B4518-5F41-4A47-8148-15B12C51FACDQ24564267-C3F9E282-F137-4757-AA81-DEB97ADE9A93Q24608210-041B1BC1-5A05-4ECE-B69C-B6184A1BD13EQ26745565-6C67FE3D-0D75-442E-923A-16BD3CA6F774Q26772180-3C775AC5-59CD-4ACB-B023-AB554C69F06AQ26849656-1C0355D1-784C-4644-BDC9-748E66EC2D8CQ26863249-1E37625B-438F-48A0-A403-5307BCDAB620Q26865615-4B9552DF-FE80-4D39-8AFA-0A00B58C46D5Q26996069-9A706AF2-7628-475B-8AF5-E60FEFA22957Q27004958-EF928B79-AEF4-4392-B444-F35E91C1C993Q27013664-F9E7ACC3-AD25-411B-8C67-FBE3EF75D1C1Q27306938-99C627C1-5C3E-4E6B-A1F6-BAAEB228C709Q27727742-39F97BB2-AE2B-47EC-BFF0-97D4718C71F6Q27852713-A23C914B-3A47-4A80-86FF-C550BA65B35DQ28070315-E12FC5CC-657A-40D3-BD87-60CC7B5F9408Q28075715-FB6EC970-E122-45FF-B698-6F1A9AE38F74Q28084968-380A924A-39E4-46DE-BD0B-5AF93398B970Q28282509-E14F2392-FE2F-4504-A029-64C92723D4AAQ28485143-1E62C3C7-4124-4920-B0A9-CDA3F78F0BE2Q28593691-3178D501-15A3-4749-BC24-297C610D767BQ28817755-3208824B-EB5A-4C6F-8296-DDAA0E6BBBC2Q30430629-AB608202-01CB-4F44-BFE8-2C0D98CE3901Q30449753-89C0A528-7A7F-4F3B-AF7D-713D2E99A615Q30496623-6C741732-2D81-421A-AED2-17F109057051Q30583897-603E8159-E393-45C6-ABAA-0AA5FAA1263AQ33576030-2D80DB75-057E-425F-8B26-D65B6B409EEAQ33598470-BD70F6E5-2984-4B83-A5B6-4EDAD7109BFBQ33637052-4DAE97B8-DCB9-4B51-99C8-D60E14C57FE0Q33665288-D72766BE-07C2-434A-85CA-7E0F6864E40AQ33820258-FE760602-59D0-4D0B-AF22-ACC8521CAB29Q33839166-DBF6783A-632C-4800-AB63-4C011B7B3EE7Q33898816-418FDF02-86AB-40EC-B70A-A0F959D74F66Q33912608-0A679F39-EB49-4F18-BAA5-9952AD278307Q33918093-8F9511F6-B667-401F-A9B1-B3E3BD3DF489Q33982978-6262B9B1-F19D-4801-811E-7EE1F3D34534Q33990937-CBF8395A-AACF-42E5-89E0-8443CBB43D1CQ33991012-83F701AF-B62F-4D4C-BD64-7F113DD34B86Q34008245-98AE206C-1EF7-402A-B1DE-1EEF3FEA7C1CQ34025284-5BE81C7C-6FA3-417F-9DE6-31456DEA7B3EQ34049627-7FE52C74-CC3D-42D0-A88E-756DA711A875
P2860
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@en
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@nl
type
label
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@en
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@nl
prefLabel
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@en
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@nl
P2093
P2860
P356
P1476
Matrix metalloproteinases as n ...... eutic targets in human cancer.
@en
P2093
Jiang Yang
Marsha A Moses
Roopali Roy
P2860
P304
P356
10.1200/JCO.2009.23.5556
P407
P577
2009-09-08T00:00:00Z